Esticast Logo
Get In Touch!

Cancer Vaccine Market By Type ( Therapeutic Cancer Vaccine, Preventive Cancer vaccine ), By Indication ( Cervical Cancer,Prostate cancer, Breast Cancer, Lung Cancer ), By End-User ( Pediatric Cancer Vaccine, Adult Cancer Vaccine ), Industry Trends, Estimation & Forecast, 2017 - 2025

  • Published On: May, 2018
  • Category: Healthcare
  • Pages: 178
Cancer Vaccine Market is expected to grow with a CAGR of 17.5% during the forecast period of 2018 to 2025.

Market Overview:

Cancer vaccines have evolved as one of the best medical revolutionary innovations that act as an adjuvant and a viable option for treating various types of cancers such as breast cancer, blood cancer, kidney cancer, lung cancer, bladder cancer and various others. The increasing consumption of tobacco & alcohol and the sedentary lifestyle of people are leading to the rise in number of cancer patients across the globe, which in turn is driving the growth of cancer vaccines market. As per breastcancer.org, one out of eight women in the U.S. is suffering from invasive breast cancer. Similarly, as per the data revealed by the Europa Donna, in the European union, every one out of eight women is expected to acquire breast cancer before the age of 85 years. Such alarming statistics are expected to increase the demand for cancer vaccines in the global market. Moreover, continuously growing R&D activities, adoption of new cancer vaccines delivery technologies and fast onset of action and reformulation of cancer vaccines in order to decrease side effects are emerging out as the highly contributing factor for the growth of the very market. In the current scenario, cancer is considered to be one of the most complex genetic disease. This is the reason, cancer vaccines are preferred to kill the cancer cells and restrain the sudden mutations. However, lack of awareness, high cost of these vaccines might act as a restraining factor for the growth of the very market. In addition, lack of early detection facilities & appropriate screening of breast cancer patients may also restrict the global market growth. The report provides detailed qualitative and quantitative analysis of the global cancer vaccine market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type and indication and end-user in each of the major regions.

Cancer Vaccine Market Segmentation

By Type • Therapeutic Cancer Vaccine • Preventive Cancer vaccine By Indication • Cervical Cancer • Prostate cancer • Breast Cancer • Lung Cancer • Others By End-User • Pediatric Cancer Vaccine • Adult Cancer Vaccine By Geography • North America o U.S. o Canada o Mexico • Europe o U.K. o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America • Rest of the World o Middle East o Africa

CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. CANCER VACCINE MARKET OVERVIEW 2.1. CANCER VACCINE MARKET INTRODUCTION 2.2. GLOBAL CANCER VACCINE MARKET PRODUCTION AND GROWTH RATE, 2017-2025 2.2.1. Global Cancer Vaccine Production (VOLUME) and Growth Rate (%), (2017-2025) 2.3. GLOBAL CANCER VACCINE MARKET CAPACITY AND GROWTH RATE, 2017-2025 2.3.1. Global Cancer Vaccine Capacity (VOLUME) and Growth Rate (%), (2017-2025) 2.4. GLOBAL CANCER VACCINE MARKET REVENUE AND GROWTH RATE, 2017-2025 2.4.1. Global Cancer Vaccine Market Revenue (Million USD) and Growth Rate (%), (2017-2025) 2.5. GLOBAL CANCER VACCINE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025 2.5.1. Global Cancer Vaccine Consumption (VOLUME) and Growth Rate (%), (2017-2025) 2.6. GLOBAL CANCER VACCINE MARKET PRICE TREND, 2017-2025 2.6.1. Global Cancer Vaccine Market Price Trend and Growth Rate (%), (2017-2025) CHAPTER 3. GLOBAL CANCER VACCINE MARKET BY TYPE, 2017-2025 3.1. THERAPEUTIC CANCER VACCINE 3.2. PREVENTIVE CANCER VACCINE 3.3. GLOBAL CANCER VACCINE MARKET REVENUE BY TYPE, 2017-2025 3.3.1. Global Cancer Vaccine Market Revenue (Million USD) and Share (%) By Type, 2017-2025 3.3.2. Therapeutic Cancer Vaccine Market Revenue and Growth Rate, 2017-2025 3.3.3. Preventive Cancer vaccine Market Revenue and Growth Rate, 2017-2025 3.4. GLOBAL CANCER VACCINE MARKET PRODUCTION BY TYPE, 2017-2025 3.4.1. Global Cancer Vaccine Market Production (Volume) and Share (%) By Type, 2017-2025 3.4.2. Therapeutic Cancer Vaccine Market Production and Growth Rate, 2017-2025 3.4.3. Preventive Cancer vaccine Market Production and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for Indication segment. CHAPTER 4. GLOBAL CANCER VACCINE MARKET BY END-USER, 2017-2025 4.1. PEDIATRIC CANCER VACCINE 4.2. ADULT CANCER VACCINE 4.3. GLOBAL CANCER VACCINE MARKET REVENUE BY END-USER, 2017-2025 4.3.1. Global Cancer Vaccine Market Revenue (Million USD) and Share (%) By End-user, 2017-2025 4.3.2. Pediatric Cancer Vaccine Market Revenue and Growth Rate, 2017-2025 4.3.3. Adult Cancer Vaccine Market Revenue and Growth Rate, 2017-2025 4.4. GLOBAL CANCER VACCINE MARKET CONSUMPTION BY END-USER, 2017-2025 4.4.1. Global Cancer Vaccine Market Consumption (Volume) and share (%) By End-user, 2017-2025 4.4.2. Pediatric Cancer Vaccine Market Consumption and Growth Rate, 2017-2025 4.4.3. Adult Cancer Vaccine Market Consumption and Growth Rate, 2017-2025 CHAPTER 5. GLOBAL CANCER VACCINE MARKET BY REGION, 2017-2025 5.1. NORTH AMERICA 5.1.1. U.S. 5.1.2. Canada 5.1.3. Mexico 5.2. EUROPE 5.2.1. U.K. 5.2.2. France 5.2.3. Germany 5.2.4. Italy 5.2.5. Spain 5.2.6. Rest of Europe 5.3. ASIA PACIFIC 5.3.1. China 5.3.2. Japan 5.3.3. India 5.3.4. Korea 5.3.5. Rest of APAC 5.4. SOUTH AMERICA 5.4.1. Brazil 5.4.2. Rest of South America 5.5. REST OF THE WORLD 5.5.1. Middle East 5.5.2. Africa 5.6. GLOBAL CANCER VACCINE MARKET REVENUE BY REGION, 2017-2025 5.6.1. Global Cancer Vaccine Market Revenue (Million USD) and Share (%) By Region, 2017-2025 5.6.2. North America Market Revenue and Growth Rate, 2017-2025 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025 5.6.5. South America Market Revenue and Growth Rate, 2017-2025 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025 CHAPTER 6. GLOBAL CANCER VACCINE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025 6.1. GLOBAL CANCER VACCINE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 6.1.1. Global Cancer Vaccine Market Production (Volume) and Share (%) By Region, 2017-2025 6.1.2. Global Cancer Vaccine Market Consumption (Volume) and Share (%) By Region, 2017-2025 6.1.3. North America Market Production and Consumption, 2017-2025 6.1.4. Europe Market Production and Consumption, 2017-2025 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025 6.1.6. South America Market Production and Consumption, 2017-2025 6.1.7. Rest of the World Market Production and Consumption, 2017-2025 CHAPTER 7. MARKET DETERMINANTS 7.1. MARKET DRIVERS 7.2. MARKET RESTRAINTS 7.3. MARKET OPPORTUNITIES 7.4. MARKET DETERMINANTS RADAR CHART CHAPTER 8. GLOBAL CANCER VACCINE MARKET COMPETITION BY MANUFACTURERS 8.1. GLOBAL CANCER VACCINE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) 8.1.1. Global Cancer Vaccine Production (VOLUME) and Share (%) by Manufacturers (2017-2025) 8.2. GLOBAL CANCER VACCINE REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 8.2.1. Global Cancer Vaccine Revenue (Million USD) and Share (%) by Manufacturers (2017-2025) 8.3. CANCER VACCINE MARKET COMPETITIVE SITUATION AND TRENDS 8.3.1. Cancer Vaccine Market Share (%) of Top 3 Manufacturers 8.3.2. Cancer Vaccine Market Share (%) of Top 5 Manufacturers CHAPTER 9. GLOBAL CANCER VACCINE MANUFACTURERS ANALYSIS 9.1. ADURO BIOTECH INC. 9.1.1. Business Overview 9.1.2. Company Basic Information 9.1.3. Cancer Vaccine Product Details 9.1.4. Aduro Biotech Inc. Cancer Vaccine Production, Revenue and Gross Margin 9.2. SANPOWER GROUP 9.2.1. Business Overview 9.2.2. Company Basic Information 9.2.3. Cancer Vaccine Product Details 9.2.4. Sanpower Group Cancer Vaccine Production, Revenue and Gross Margin 9.3. SANOFI PASTEUR 9.3.1. Business Overview 9.3.2. Company Basic Information 9.3.3. Cancer Vaccine Product Details 9.3.4. Sanofi Pasteur Cancer Vaccine Production, Revenue and Gross Margin 9.4. PFIZER INC. 9.4.1. Business Overview 9.4.2. Company Basic Information 9.4.3. Cancer Vaccine Product Details 9.4.4. Pfizer Inc. Cancer Vaccine Production, Revenue and Gross Margin 9.5. SERUM INSTITUTE OF INDIA PVT. LTD. 9.5.1. Business Overview 9.5.2. Company Basic Information 9.5.3. Cancer Vaccine Product Details 9.5.4. Serum Institute of India Pvt. Ltd. Cancer Vaccine Production, Revenue and Gross Margin 9.6. GLAXOSMITHKLINE PLC. 9.6.1. Business Overview 9.6.2. Company Basic Information 9.6.3. Cancer Vaccine Product Details 9.6.4. GlaxoSmithKline Plc. Cancer Vaccine Production, Revenue and Gross Margin 9.7. CSL LIMITED 9.7.1. Business Overview 9.7.2. Company Basic Information 9.7.3. Cancer Vaccine Product Details 9.7.4. CSL Limited Cancer Vaccine Production, Revenue and Gross Margin 9.8. MERCK & CO. INC. 9.8.1. Business Overview 9.8.2. Company Basic Information 9.8.3. Cancer Vaccine Product Details 9.8.4. Merck & Co. Inc. Cancer Vaccine Production, Revenue and Gross Margin CHAPTER 10. CANCER VACCINE MARKET VALUE CHAIN ANALYSIS 10.1. CANCER VACCINE INDUSTRIAL CHAIN ANALYSIS 10.2. CANCER VACCINE KEY RAW MATERIALS ANALYSIS 10.2.1. Key Raw Materials 10.2.2. Price Trend of Key Raw Materials 10.2.3. Key Suppliers of Raw Materials 10.3. CONSUMER ANALYSIS 10.3.1. Consumer 1 10.3.2. Consumer 2 10.3.3. Consumer 3 10.3.4. Consumer 4

• Aduro Biotech Inc.
• Sanpower Group
• Sanofi Pasteur
• Pfizer Inc.
• Serum Institute of India Pvt. Ltd.
• GlaxoSmithKline Plc.
• CSL Limited
• Merck & Co. Inc.

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS

Esticast Logo

CORPORATE OFFICE

location  (US)

1055 West 7th Street, Los Angeles, CA 90017 (P) US

phone  +1-213-262-0704
location  (APAC Address)

Office No. 407, Navale Icon IT Park, Near Navale Bridge, Narhe, Pune, Maharashtra 411041

phone  +91-959-503-5024

COMPANY

SECURE ONLINE PAYMENTS

  • visa
  • mastercard
  • amex
  • discover

FOLLOW US

  • facebook
  • linkedin
  • phone
  • youtube
© 2022 | All Rights Reserved by Esticast Research & Consulting